You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

TRYMEX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Trymex patents expire, and what generic alternatives are available?

Trymex is a drug marketed by Savage Labs and is included in five NDAs.

The generic ingredient in TRYMEX is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Trymex

A generic version of TRYMEX was approved as triamcinolone acetonide by TARO on October 1st, 1986.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for TRYMEX?
  • What are the global sales for TRYMEX?
  • What is Average Wholesale Price for TRYMEX?
Summary for TRYMEX
US Patents:0
Applicants:1
NDAs:5
Raw Ingredient (Bulk) Api Vendors: 82
Patent Applications: 4,321
DailyMed Link:TRYMEX at DailyMed
Drug patent expirations by year for TRYMEX

US Patents and Regulatory Information for TRYMEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Savage Labs TRYMEX triamcinolone acetonide CREAM;TOPICAL 088196-001 Mar 25, 1983 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Savage Labs TRYMEX triamcinolone acetonide OINTMENT;TOPICAL 088693-001 Aug 2, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Savage Labs TRYMEX triamcinolone acetonide CREAM;TOPICAL 088197-001 Mar 25, 1983 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Savage Labs TRYMEX triamcinolone acetonide CREAM;TOPICAL 088198-001 Mar 25, 1983 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Savage Labs TRYMEX triamcinolone acetonide OINTMENT;TOPICAL 088691-001 Aug 2, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.